Cargando…
Eculizumab use in patients with pneumococcal-associated hemolytic uremic syndrome and kidney outcomes
BACKGROUND: Streptococcus pneumoniae-associated hemolytic uremic syndrome (P-HUS) is a rare and severe disease. Only a few reports have been published about eculizumab use in P-HUS. METHODS: We analyzed demographic, clinical, and laboratory data of patients with P-HUS from our center. RESULTS: The c...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10584715/ https://www.ncbi.nlm.nih.gov/pubmed/37306721 http://dx.doi.org/10.1007/s00467-023-06037-2 |